Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice

Journal of Lipid Research

Volumn 58, Issue 7, 2017, Pages 1417-1427

  Yang, Ping ^a   Xiao, Yayun ^a   Luo, Xuan ^a   Zhao, Yunfei ^b   Zhao, Lei ^a   Wang, Yan ^a   Wu, Tingting ^a   Wei, Li ^a   Chen, Yaxi ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING UNIVERSITY OF EDUCATION   (China)

Author keywords

Cluster of differentiation 36; Cytokines; Ectopic lipid deposition; Fatty acid transport; Lipids; Receptors; Renal disease

Indexed keywords

CD36 ANTIGEN; CASEIN; FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRESS; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVATION; FATTY ACID TRANSPORT; GLOMERULAR DYSFUNCTION; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; IN VITRO STUDY; INFLAMMATION; KIDNEY CELL LINE; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TUBULE DAMAGE; LIPID DIET; LIPID RAFT; LIPID STORAGE; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL STEATOSIS; ANIMAL; C57BL MOUSE; CELL MEMBRANE; CHEMICALLY INDUCED; COMPLICATION; DEFICIENCY; DRUG EFFECTS; GENE KNOCKOUT; GENETICS; INTRACELLULAR SPACE; KIDNEY; METABOLISM; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL; UPREGULATION;

ANIMALS; BIOLOGICAL TRANSPORT; CASEINS; CD36 ANTIGENS; CELL MEMBRANE; DIET, HIGH-FAT; FATTY ACIDS; GENE KNOCKOUT TECHNIQUES; HUMANS; INFLAMMATION; INTRACELLULAR SPACE; KIDNEY; MICE; MICE, INBRED C57BL; OBESITY; RENAL INSUFFICIENCY, CHRONIC; UP-REGULATION;

EID: 85021733905     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M076216     Document Type: Article

References (47)

1. Wahba, I. M., and R. H. Mak. 2007. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2: 550–562.
2. Iseki, K., Y. Ikemiya, K. Kinjo, T. Inoue, C. Iseki, and S. Takishita. 2004. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 65: 1870–1876.
3. Hsu, C. Y., C. E. McCulloch, C. Iribarren, J. Darbinian, and A. S. Go. 2006. Body mass index and risk for end-stage renal disease. Ann. Intern. Med. 144: 21–28.
4. Ejerblad, E., C. M. Fored, P. Lindblad, J. Fryzek, J. K. McLaughlin, and O. Nyren. 2006. Obesity and risk for chronic renal failure. J. Am. Soc. Nephrol. 17: 1695–1702.
5. St Peter, J. V., G. G. Hartley, M. M. Murakami, and F. S. Apple. 2006. B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery. Clin. Chem. 52: 680–685.
6. McIntyre, N. 1988. Familial LCAT deficiency and fish-eye disease. J. Inherit. Metab. Dis. 11 (Suppl. 1): 45–56.
7. Noori, N., F. Hosseinpanah, A. A. Nasiri, and F. Azizi. 2009. Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J. Ren. Nutr. 19: 228–237.
8. Kambham, N., G. S. Markowitz, A. M. Valeri, J. Lin, and V. D. D’Agati. 2001. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 59: 1498–1509.
9. Tsuboi, N., Y. Utsunomiya, and T. Hosoya. 2013. Obesity-related glomerulopathy and the nephron complement. Nephrol. Dial. Transplant. 28 (Suppl. 4): iv108–iv113.
10. Praga, M., E. Hernandez, E. Morales, A. P. Campos, M. A. Valero, M. A. Martinez, and M. Leon. 2001. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 16: 1790–1798.
11. Reaven, G. M. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 37: 1595–1607.
12. Oterdoom, L. H., A. P. de Vries, R. T. Gansevoort, P. E. de Jong, R. O. Gans, and S. J. Bakker. 2007. Fasting insulin modifies the relation between age and renal function. Nephrol. Dial. Transplant. 22: 1587–1592.
13. Carrero, J. J., and P. Stenvinkel. 2009. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin. J. Am. Soc. Nephrol. 4 (Suppl. 1): S49–S55.
14. Wu, Y., Z. Liu, Z. Xiang, C. Zeng, Z. Chen, X. Ma, and L. Li. 2006. Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology. 147: 44–50.
15. Miyamoto, T., J. J. Carrero, and P. Stenvinkel. 2011. Inflammation as a risk factor and target for therapy in chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 20: 662–668.
16. Ma, K. L., X. Z. Ruan, S. H. Powis, Y. Chen, J. F. Moorhead, and Z. Varghese. 2008. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice. Hepatology. 48: 770–781.
17. Chen, Y., Y. Chen, L. Zhao, Y. Chen, M. Mei, Q. Li, A. Huang, Z. Varghese, J. F. Moorhead, and X. Z. Ruan. 2012. Inflammatory stress exacerbates hepatic cholesterol accumulation via disrupting cellular cholesterol export. J. Gastroenterol. Hepatol. 27: 974–984.
18. Zhao, L., Y. Chen, R. Tang, Y. Chen, Q. Li, J. Gong, A. Huang, Z. Varghese, J. F. Moorhead, and X. Z. Ruan. 2011. Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis. J. Gastroenterol. Hepatol. 26: 875–883.
19. Mei, M., L. Zhao, Q. Li, Y. Chen, A. Huang, Z. Varghese, J. F. Moorhead, S. Zhang, S. H. Powis, Q. Li, et al. 2011. Inflammatory stress exacerbates ectopic lipid deposition in C57BL/6J mice. Lipids Health Dis. 10: 110.
20. Weinberg, J. M. 2006. Lipotoxicity. Kidney Int. 70: 1560–1566.
21. Wallin, T., Z. Ma, H. Ogata, I. H. Jorgensen, M. Iezzi, H. Wang, C. B. Wollheim, and A. Bjorklund. 2010. Facilitation of fatty acid uptake by CD36 in insulin-producing cells reduces fatty-acid-induced insulin secretion and glucose regulation of fatty acid oxidation. Biochim. Biophys. Acta. 1801: 191–197.
22. Febbraio, M., D. P. Hajjar, and R. L. Silverstein. 2001. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108: 785–791.
23. Baines, R. J., and N. J. Brunskill. 2011. Tubular toxicity of proteinuria. Nat. Rev. Nephrol. 7: 177–180.
24. Hua, W., H. Z. Huang, L. T. Tan, J. M. Wan, H. B. Gui, L. Zhao, X. Z. Ruan, X. M. Chen, and X. G. Du. 2015. CD36 mediated fatty acid-induced podocyte apoptosis via oxidative stress. PLoS One. 10: e0127507.
25. Susztak, K., E. Ciccone, P. McCue, K. Sharma, and E. P. Böttinger. 2005. Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy. PLoS Med. 2: e45.
26. Okamura, D. M., S. Pennathur, K. Pasichnyk, J. M. López-Guisa, S. Collins, M. Febbraio, J. Heinecke, and A. A. Eddy. 2009. CD36 regulates oxidative stress and inflammation in hypercholesterol-emic CKD. J. Am. Soc. Nephrol. 20: 495–505.
27. Zeaiter, Z., D. Cohen, A. Müsch, F. Bagnoli, A. Covacci, and M. Stein. 2008. Analysis of detergent-resistant membranes of Helicobacter pylori infected gastric adenocarcinoma cells reveals a role for MARK2/ Par1b in CagA-mediated disruption of cellular polarity. Cell. Microbiol. 10: 781–794.
28. Wu, Y., T. Wu, J. Wu, L. Zhao, Q. Li, Z. Varghese, J. F. Moorhead, S. H. Powis, Y. Chen, and X. Z. Ruan. 2013. Chronic inflammation exacerbates glucose metabolism disorders in C57BL/6J mice fed with high-fat diet. J. Endocrinol. 219: 195–204.
29. Xu, Z. E., Y. Chen, A. Huang, Z. Varghese, J. F. Moorhead, F. Yan, S. H. Powis, Q. Li, and X. Z. Ruan. 2011. Inflammatory stress exacerbates lipid-mediated renal injury in ApoE/CD36/SRA triple knockout mice. Am. J. Physiol. Renal Physiol. 301: F713–F722.
30. Eyre, N. S., L. G. Cleland, N. N. Tandon, and G. Mayrhofer. 2007. Importance of the carboxyl terminus of FAT/CD36 for plasma membrane localization and function in long-chain fatty acid uptake. J. Lipid Res. 48: 528–542.
31. Ruan, X. Z., Z. Varghese, and J. F. Moorhead. 2009. An update on the lipid nephrotoxicity hypothesis. Nat. Rev. Nephrol. 5: 713–721.
32. Deji, N., S. Kume, S. Araki, M. Soumura, T. Sugimoto, K. Isshiki, M. Chin-Kanasaki, M. Sakaguchi, D. Koya, M. Haneda, et al. 2009. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am. J. Physiol. Renal Physiol. 296: F118–F126.
33. Jiang, T., Z. Wang, G. Proctor, S. Moskowitz, S. E. Liebman, T. Rogers, M. S. Lucia, J. Li, and M. Levi. 2005. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J. Biol. Chem. 280: 32317–32325.
34. Kume, S., T. Uzu, S. Araki, T. Sugimoto, K. Isshiki, M. Chin-Kanasaki, M. Sakaguchi, N. Kubota, Y. Terauchi, T. Kadowaki, et al. 2007. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J. Am. Soc. Nephrol. 18: 2715–2723.
35. Moorhead, J. F., M. K. Chan, M. El-Nahas, and Z. Varghese. 1982. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. 2: 1309–1311.
36. Kamanna, V. S., D. D. Roh, and M. A. Kirschenbaum. 1998. Hyperlipidemia and kidney disease: concepts derived from histo-pathology and cell biology of the glomerulus. Histol. Histopathol. 13: 169–179.
37. Lee, P. H., H. Y. Chang, C. W. Tung, Y. C. Hsu, C. C. Lei, H. H. Chang, H. F. Yang, L. C. Lu, M. C. Jong, C. Y. Chen, et al. 2009. Hypertriglyceridemia: an independent risk factor of chronic kidney disease in Taiwanese adults. Am. J. Med. Sci. 338: 185–189.
38. Tozawa, M., K. Iseki, C. Iseki, S. Oshiro, Y. Ikemiya, and S. Takishita. 2002. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int. 62: 1743–1749.
39. de Vries, A. P., P. Ruggenenti, X. Z. Ruan, M. Praga, J. M. Cruzado, I. M. Bajema, V. D. D’Agati, H. J. Lamb, D. Pongrac Barlovic, R. Hojs, et al. 2014. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2: 417–426.
40. Zhong, S., L. Zhao, Q. Li, P. Yang, Z. Varghese, J. F. Moorhead, Y. Chen, and X. Z. Ruan. 2015. Inflammatory stress exacerbated mesangial foam cell formation and renal injury via disrupting cellular cholesterol homeostasis. Inflammation. 38: 959–971.
41. Feingold, K. R., Y. Wang, A. Moser, J. K. Shigenaga, and C. Grunfeld. 2008. LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney. J. Lipid Res. 49: 2179–2187.
42. Zager, R. A., A. C. Johnson, and S. Y. Hanson. 2005. Renal tubular triglyercide accumulation following endotoxic, toxic, and ischemic injury. Kidney Int. 67: 111–121.
43. Khovidhunkit, W., M-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld. 2004. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 45: 1169–1196.
44. Silverstein, R. L., and M. Febbraio. 2009. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci. Signal. 2: re3.
45. Stewart, C. R., L. M. Stuart, K. Wilkinson, J. M. van Gils, J. Deng, A. Halle, K. J. Rayner, L. Boyer, R. Zhong, and W. A. Frazier. 2010. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11: 155–161.
46. Souza, A. C. P., A. V. Bocharov, I. N. Baranova, T. G. Vishnyakova, Y. G. Huang, K. J. Wilkins, X. Hu, J. M. Street, A. Alvarez-Prats, and A. E. Mullick. 2016. Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation. Kidney Int. 89: 809–822.
47. Wang, C., L. Hu, L. Zhao, P. Yang, J. F. Moorhead, Z. Varghese, Y. Chen, and X. Z. Ruan. 2014. Inflammatory stress increases hepatic CD36 translational efficiency via activation of the mTOR sig-nalling pathway. PLoS One. 9: e103071.